HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Poly (D,L-lactic-co-glycolide) nanoparticles for the improved therapeutic efficacy of all-trans-retinoic acid: a study of acute myeloid leukemia (AML) cell differentiation in vitro.

Abstract
All-trans-retinoic acid reverses malignant cell growth and induces cell differentiation and apoptosis. Poor aqueous solubility and uncertain bioavailability are the limiting factors for using all-trans-retinoic acid for tumor therapy. The objective of present study was to encapsulate the hydrophobic drug all-trans-retinoic acid in the polymer poly (lactide-coglycolide). The encapsulation was expected to improve the bioavailability and solubility of the drug. Oil in water single emulsion solvent evaporation technique used for the preparation efficiently encapsulated about 60% of the drug. The drug release profile showed a biphasic pattern with 70% of the drug being released in first 48 hrs and the residual drug showing a slow controlled release reaching up to 8 days. The particle size of 150-200 nm as determined with TEM was ideal for tumor targeting. All-trans-retinoic acid loaded nanoparticles were efficient to induce differentiation and blocked the proliferation of HL-60 cells invitro. These studies also revealed that the dosage of drug required for the therapeutic effects have been reduced efficiently. Our studies thereby demonstrate that Poly (lactide-co-glycolide) based nanoparticles may be efficient for parenteral administration of the drug.
AuthorsAswathy Mary Simon, Sankar Jagadeeshan, Emimol Abraham, Ashalatha Akhilandeshwaran, Jisha J Pillai, Nisha Asok Kumar, Asha Nair Sivakumari, Gopalakrishnapillai Sankaramangalam Vinod Kumar
JournalMedicinal chemistry (Shariqah (United Arab Emirates)) (Med Chem) Vol. 8 Issue 5 Pg. 805-10 (Sep 2012) ISSN: 1875-6638 [Electronic] Netherlands
PMID22741806 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Drug Carriers
  • Emulsions
  • Polyglactin 910
  • Tretinoin
Topics
  • Antineoplastic Agents (chemistry, pharmacology)
  • Cell Differentiation
  • Drug Carriers (chemical synthesis, chemistry)
  • Drug Compounding
  • Emulsions
  • HL-60 Cells (drug effects)
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Kinetics
  • Leukemia, Myeloid, Acute (drug therapy, pathology)
  • Microscopy, Electron, Transmission
  • Nanoparticles (chemistry)
  • Particle Size
  • Polyglactin 910 (chemistry)
  • Solubility
  • Tretinoin (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: